BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14691350)

  • 1. Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications.
    Krämer BK; Kammerl MC; Kömhoff M
    Kidney Blood Press Res; 2004; 27(1):43-62. PubMed ID: 14691350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 and the renal renin-angiotensin system.
    Harris RC; Zhang MZ; Cheng HF
    Acta Physiol Scand; 2004 Aug; 181(4):543-7. PubMed ID: 15283769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 and the kidney: functional and pathophysiological implications.
    Harris RC
    J Hypertens Suppl; 2002 Sep; 20(6):S3-9. PubMed ID: 12683421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between COX-2 and the renin-angiotensin system in the kidney.
    Harris RC
    Acta Physiol Scand; 2003 Apr; 177(4):423-7. PubMed ID: 12648159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression and function in renal pathophysiology.
    Komers R; Epstein M
    J Hypertens Suppl; 2002 Sep; 20(6):S11-5. PubMed ID: 12683422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclooxygenase-2 in the control of renal haemodynamics and excretory function.
    López R; Roig F; Llinás MT; Salazar FJ
    Acta Physiol Scand; 2003 Apr; 177(4):429-35. PubMed ID: 12648160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Komers R; Anderson S; Epstein M
    Am J Kidney Dis; 2001 Dec; 38(6):1145-57. PubMed ID: 11728945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system in kidney development: role of COX-2 and adrenal steroids.
    Jensen BL; Stubbe J; Madsen K; Nielsen FT; Skøtt O
    Acta Physiol Scand; 2004 Aug; 181(4):549-59. PubMed ID: 15283770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cyclooxygenase-2 affect blood pressure?
    Cheng HF; Harris RC
    Curr Hypertens Rep; 2003 Feb; 5(1):87-92. PubMed ID: 12530941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenases, the kidney, and hypertension.
    Cheng HF; Harris RC
    Hypertension; 2004 Mar; 43(3):525-30. PubMed ID: 14732722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of macula densa cyclooxygenase-2 in renovascular hypertension.
    Hartner A; Cordasic N; Goppelt-Struebe M; Veelken R; Hilgers KF
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F498-502. PubMed ID: 12429553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological regulation of cyclooxygenase-2 in the kidney.
    Harris RC; Breyer MD
    Am J Physiol Renal Physiol; 2001 Jul; 281(1):F1-11. PubMed ID: 11399641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors.
    Braden GL; O'Shea MH; Mulhern JG; Germain MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1149-53. PubMed ID: 14993496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake.
    Höcherl K; Kammerl MC; Schumacher K; Endemann D; Grobecker HF; Kurtz A
    Am J Physiol Renal Physiol; 2002 Aug; 283(2):F294-301. PubMed ID: 12110513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macula densa signalling--a potential role of cyclooxygenase-2 (COX-2)?
    Harris RC
    Nephrol Dial Transplant; 2000 Oct; 15(10):1504-6. PubMed ID: 11007811
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of nNOS expression in the macula densa by COX-2-derived prostaglandin E(2).
    Paliege A; Mizel D; Medina C; Pasumarthy A; Huang YG; Bachmann S; Briggs JP; Schnermann JB; Yang T
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F152-9. PubMed ID: 15010356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G; Giovanni P
    J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 and kidney failure.
    Rios A; Vargas-Robles H; Gámez-Méndez AM; Escalante B
    Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):86-90. PubMed ID: 22119250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system.
    Castrop H; Klar J; Wagner C; Hocherl K; Kurtz A
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F518-24. PubMed ID: 12441308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
    Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
    J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.